（活力中国调研行）北京加快培育壮大未来产业

Core Insights - The Beijing pharmaceutical and health industry reached a scale of 1.06 trillion yuan in 2024, with a year-on-year growth of 8.7%, indicating a significant acceleration towards becoming a globally influential modern pharmaceutical and health industry cluster [1] Group 1: Industry Development - The Beijing municipal government has implemented three rounds of action plans since 2018 to accelerate collaborative innovation in the pharmaceutical and health sector, establishing a dual leadership mechanism between technology management and industry management departments [1][2] - In 2024 and 2025, Beijing introduced measures to promote high-quality development in the pharmaceutical sector, attracting eight well-known pharmaceutical companies to establish innovative entities in the city [2] Group 2: Talent and Investment - The city has initiated various talent training programs, including those for physician-scientists and young clinical research talents, to effectively cultivate urgently needed professionals in the industry [2] - A municipal-level investment fund of 20 billion yuan has been established to support innovation and development in the pharmaceutical and health sector [2] Group 3: Technological Advancements - Beijing boasts a concentration of technological resources, including universities and research institutions, which support the design and modification of microorganisms, leading to innovative outcomes in key technology areas [3] - The city has a leading clinical level with numerous national clinical research centers and medical centers, housing expert teams with extensive clinical experience [3] Group 4: Emerging Industries - Significant progress has been made in brain-machine interface and synthetic biology manufacturing, with breakthroughs in key technologies and clinical applications [4][5] - The development of innovative products, such as the world's first efficient large fragment DNA insertion technology and advanced biomanufacturing techniques, has been achieved [5] Group 5: Future Directions - Moving forward, Beijing aims to enhance policy implementation and promote innovation-driven industry development, focusing on brain-machine interfaces and synthetic biology manufacturing to foster new productive forces [6]